Should an angiotensin-converting enzyme inhibitor be given at the time of reperfusion therapy in acute myocardial infarction?

Am Heart J. 2008 Jul;156(1):e1. doi: 10.1016/j.ahj.2008.03.029.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / administration & dosage*
  • Combined Modality Therapy
  • Coronary Artery Bypass / methods
  • Coronary Artery Bypass / mortality
  • Female
  • Humans
  • Male
  • Myocardial Infarction / mortality*
  • Myocardial Infarction / therapy*
  • Myocardial Reperfusion / methods
  • Myocardial Reperfusion / mortality*
  • Risk Assessment
  • Sensitivity and Specificity
  • Survival Analysis

Substances

  • Angiotensin-Converting Enzyme Inhibitors